Careers Contact
Careers Contact

Investors

Since 2021, Evaxion has been listed on the Nasdaq Capital Market exchange (ticker code: EVAX). Here you can find all of the latest Evaxion investor insights: our results, upcoming events and news, important shareholder updates and much more.

Latest press releases

Email alerts
View all
Dec 6, 2025

Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Nov 20, 2025

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1
Nov 12, 2025

Evaxion announce 2026 financial calendar

Upcoming events & presentations

View all
Jan 12 – Jan 15, 2026
|
San Francisco, United States
18th Biotech Showcase
Coinciding with the 44th annual J.P. Morgan Healthcare Conference, Biotech Showcase takes place on January 12-14, 2026 in San Francisco, CA. It is a leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives.
Learn more

Latest events & presentations

View all
Dec 11, 2025
|
Virtual
Sidoti Year End Virtual Investor Conference
CFO Thomas Schmidt will present our AI-Immunology™ platform, pipeline and strategy at the virtual Sidoti Year End Conference on Thu, Dec 11 at 8:30AM ET/14:30 CET.
Learn more
Q3

Latest quarterly report

View all financial reports
Presentation Presentation Webcast Webcast Transcript Transcript Press release Press release

Contact IR

Mads Kronborg
Vice President, Investor Relations & Communication
Email: mak@evaxion.ai
Telephone: +45 53 54 82 96

For general investor relations inquiries please use the contact form below

Company presentation

Stay in touch

LinkedIn
Follow Evaxion on LinkedIn to engage, connect, and stay informed.
Follow us
Twitter
Join the conversation and stay updated with Evaxion on X.
Follow us
Subscribe to email news alerts
Join our mailing list to get our latest press releases delivered straight to your inbox.
Sign up